- Home
- WNW vs ATNF Comparison
WNW vs ATNF Comparison
Compare WNW & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- ATNF
- Stock Information
- Founded
- WNW 2015
- ATNF 2016
- Country
- WNW China
- ATNF United States
- Employees
- WNW N/A
- ATNF N/A
- Industry
- WNW Catalog/Specialty Distribution
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- ATNF Health Care
- Exchange
- WNW Nasdaq
- ATNF Nasdaq
- Market Cap
- WNW 5.7M
- ATNF 5.0M
- IPO Year
- WNW 2020
- ATNF N/A
- Fundamental
- Price
- WNW $1.69
- ATNF $7.04
- Analyst Decision
- WNW
- ATNF
- Analyst Count
- WNW 0
- ATNF 0
- Target Price
- WNW N/A
- ATNF N/A
- AVG Volume (30 Days)
- WNW 15.8K
- ATNF 21.8M
- Earning Date
- WNW 08-26-2025
- ATNF 07-23-2025
- Dividend Yield
- WNW N/A
- ATNF N/A
- EPS Growth
- WNW N/A
- ATNF N/A
- EPS
- WNW 9.06
- ATNF N/A
- Revenue
- WNW $158,485.00
- ATNF N/A
- Revenue This Year
- WNW N/A
- ATNF N/A
- Revenue Next Year
- WNW N/A
- ATNF N/A
- P/E Ratio
- WNW $0.19
- ATNF N/A
- Revenue Growth
- WNW N/A
- ATNF N/A
- 52 Week Low
- WNW $0.95
- ATNF $0.66
- 52 Week High
- WNW $70.00
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- WNW 40.81
- ATNF 63.18
- Support Level
- WNW $1.66
- ATNF $2.94
- Resistance Level
- WNW $1.82
- ATNF $17.46
- Average True Range (ATR)
- WNW 0.09
- ATNF 1.83
- MACD
- WNW -0.01
- ATNF 0.49
- Stochastic Oscillator
- WNW 18.73
- ATNF 30.11
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.